Jun Arii

2.8k total citations
73 papers, 2.2k citations indexed

About

Jun Arii is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Jun Arii has authored 73 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Epidemiology, 26 papers in Molecular Biology and 26 papers in Immunology. Recurrent topics in Jun Arii's work include Herpesvirus Infections and Treatments (55 papers), Cytomegalovirus and herpesvirus research (30 papers) and Virus-based gene therapy research (20 papers). Jun Arii is often cited by papers focused on Herpesvirus Infections and Treatments (55 papers), Cytomegalovirus and herpesvirus research (30 papers) and Virus-based gene therapy research (20 papers). Jun Arii collaborates with scholars based in Japan, United States and Slovakia. Jun Arii's co-authors include Yasushi Kawaguchi, Akihisa Kato, Naoto Koyanagi, Hisashi Arase, Hiroomi Akashi, Yuhei Maruzuru, Hiroko Kozuka‐Hata, Masaaki Oyama, Tadahiro Suenaga and Takahiko Imai and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Jun Arii

71 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Arii Japan 27 1.5k 741 699 449 289 73 2.2k
Robert J. Geraghty United States 23 1.8k 1.2× 576 0.8× 599 0.9× 648 1.4× 627 2.2× 51 2.8k
Amanda D. Stuart United Kingdom 15 1.0k 0.7× 545 0.7× 391 0.6× 185 0.4× 370 1.3× 17 1.6k
Scott S. Terhune United States 25 1.3k 0.9× 647 0.9× 424 0.6× 192 0.4× 194 0.7× 60 1.9k
Huan Lou United States 30 2.3k 1.6× 583 0.8× 874 1.3× 763 1.7× 205 0.7× 45 3.1k
Zsolt Ruzsics Germany 37 1.7k 1.1× 1.8k 2.4× 1.1k 1.6× 857 1.9× 433 1.5× 90 3.8k
Derek Walsh United States 25 647 0.4× 1.1k 1.4× 421 0.6× 333 0.7× 394 1.4× 49 2.2k
Qiyi Tang United States 26 969 0.7× 706 1.0× 395 0.6× 201 0.4× 663 2.3× 94 2.1k
Igor Bačík United States 19 992 0.7× 866 1.2× 1.4k 2.0× 204 0.5× 313 1.1× 23 2.4k
Florent C. Bender United States 13 870 0.6× 502 0.7× 349 0.5× 265 0.6× 111 0.4× 18 1.6k
Laurent Coscoy United States 25 1.1k 0.8× 1.2k 1.7× 1.1k 1.5× 275 0.6× 342 1.2× 41 3.1k

Countries citing papers authored by Jun Arii

Since Specialization
Citations

This map shows the geographic impact of Jun Arii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Arii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Arii more than expected).

Fields of papers citing papers by Jun Arii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Arii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Arii. The network helps show where Jun Arii may publish in the future.

Co-authorship network of co-authors of Jun Arii

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Arii. A scholar is included among the top collaborators of Jun Arii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Arii. Jun Arii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arii, Jun. (2024). ESCRT-III-dependent and -independent egress of herpesviruses. SHILAP Revista de lepidopterología. 4. 1 indexed citations
2.
Aktar, Salma, et al.. (2024). HHV-6B ribonucleotide reductase sequesters NF-κB subunit p65 to inhibit innate immune responses. iScience. 28(2). 111710–111710.
3.
Furukawa, Koichi, et al.. (2023). Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population. Journal of Infection and Public Health. 16(7). 1064–1072. 1 indexed citations
4.
Furukawa, Koichi, Sachiko Nakamura, Mitsuhiro Nishimura, et al.. (2022). Cross-Neutralizing Activity Against Omicron Could Be Obtained in SARS-CoV-2 Convalescent Patients Who Received Two Doses of mRNA Vaccination. The Journal of Infectious Diseases. 226(8). 1391–1395. 4 indexed citations
6.
Furukawa, Koichi, Sachiko Nakamura, Mitsuhiro Nishimura, et al.. (2021). Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan. Open Forum Infectious Diseases. 8(10). ofab430–ofab430. 14 indexed citations
7.
Kato, Akihisa, Shungo Adachi, Shuichi Kawano, et al.. (2020). Identification of a herpes simplex virus 1 gene encoding neurovirulence factor by chemical proteomics. Nature Communications. 11(1). 4894–4894. 16 indexed citations
8.
Sato, Ryota, Akihisa Kato, Takahiko Chimura, et al.. (2018). Combating herpesvirus encephalitis by potentiating a TLR3–mTORC2 axis. Nature Immunology. 19(10). 1071–1082. 58 indexed citations
9.
Arii, Jun, Mizuki Watanabe, Noriko Tokai-Nishizumi, et al.. (2018). ESCRT-III mediates budding across the inner nuclear membrane and regulates its integrity. Nature Communications. 9(1). 3379–3379. 82 indexed citations
10.
Koyanagi, Naoto, Takahiko Imai, Keiko Shindo, et al.. (2017). Herpes simplex virus-1 evasion of CD8+ T cell accumulation contributes to viral encephalitis. Journal of Clinical Investigation. 127(10). 3784–3795. 36 indexed citations
11.
Kato, Akihisa, Masaaki Oyama, Hiroko Kozuka‐Hata, et al.. (2015). Interactome analysis of herpes simplex virus 1 envelope glycoprotein H. Microbiology and Immunology. 59(6). 331–337. 4 indexed citations
12.
Koyanagi, Naoto, Takahiko Imai, Jun Arii, Akihisa Kato, & Yasushi Kawaguchi. (2013). Role of herpes simplex virus 1 Us3 in viral neuroinvasiveness. Microbiology and Immunology. 58(1). 31–37. 12 indexed citations
13.
Imai, Takahiko, Naoto Koyanagi, Ryo Ogawa, et al.. (2013). Us3 Kinase Encoded by Herpes Simplex Virus 1 Mediates Downregulation of Cell Surface Major Histocompatibility Complex Class I and Evasion of CD8+ T Cells. PLoS ONE. 8(8). e72050–e72050. 40 indexed citations
15.
Kato, Akihisa, Zhuoming Liu, Takahiko Imai, et al.. (2011). Herpes Simplex Virus 1 Protein Kinase Us3 and Major Tegument Protein UL47 Reciprocally Regulate Their Subcellular Localization in Infected Cells. Journal of Virology. 85(18). 9599–9613. 39 indexed citations
16.
Azab, Walid, Kentaro Kato, Jun Arii, et al.. (2009). Cloning of the genome of equine herpesvirus 4 strain TH20p as an infectious bacterial artificial chromosome. Archives of Virology. 154(5). 833–842. 26 indexed citations
17.
Kato, Akihisa, Jun Arii, Ikuo Shiratori, et al.. (2008). Herpes Simplex Virus 1 Protein Kinase Us3 Phosphorylates Viral Envelope Glycoprotein B and Regulates Its Expression on the Cell Surface. Journal of Virology. 83(1). 250–261. 70 indexed citations
18.
Satoh, Takeshi, Jun Arii, Tadahiro Suenaga, et al.. (2008). PILRα Is a Herpes Simplex Virus-1 Entry Coreceptor That Associates with Glycoprotein B. Cell. 132(6). 935–944. 245 indexed citations
19.
Morimoto, Tomomi, Jun Arii, Hiroomi Akashi, & Yasushi Kawaguchi. (2008). Identification of multiple sites suitable for insertion of foreign genes in herpes simplex virus genomes. Microbiology and Immunology. 53(3). 155–161. 15 indexed citations
20.
Arii, Jun, et al.. (2006). Construction of an infectious clone of canine herpesvirus genome as a bacterial artificial chromosome. Microbes and Infection. 8(4). 1054–1063. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026